Thomas A. Perry

Thomas A. Perry

Auto-generated profile, based on publicly available information

Thomas A. Perry

Centre for OA Pathogenesis Versus Arthritis, Kennedy Institute of Rheumatology, University of Oxford Oxford United Kingdom

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2020 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
PDF file
NANigel K. Arden
Nigel K. Arden
TPThomas A. Perry
Thomas A. Perry
RBRaveendhara R. Bannuru
Raveendhara R. Bannuru
OBOlivier Bruyère
Olivier Bruyère
CCCyrus Cooper
Cyrus Cooper
JRJean-Yves Reginster
Jean-Yves Reginster

1 September 2020 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
XWXia Wang
Xia Wang
TPThomas A. Perry
Thomas A. Perry
NANigel Arden
Nigel Arden
LCLingxiao Chen
Lingxiao Chen
CPCamille M. Parsons
Camille M. Parsons
DHDavid Hunter
David Hunter

6 April 2020 in Physical Therapy
Verified
Journal Article
Closed access
XYXiaotian Yang
Xiaotian Yang
HHHongchen He
Hongchen He
WYWenwen Ye
Wenwen Ye
TPThomas A Perry
Thomas A Perry
CHChengqi He
Chengqi He
Objective: Pulsed electromagnetic field (PEMF) therapy is a potentially useful treatment for osteoarthritis (OA), but its effectiveness is still controversial. This study aimed to examine the effects of PEMF therapy and PEMF parameters on symptoms and quality of life (QOL) in patients with OA. Methods: Cochrane Central Register of Controlled Trials, PubMed, CINAHL, EMBASE, PEDro, clinical trial registers, and reference lists were searched until April 2019. This study examined randomized, placebo-controlled trials, patients with OA, symptom and/or QOL related outcomes, and articles published in English. Two authors extracted data and completed quality assessment. Results: Sixteen studies were included in our systematic review, while 15 studies with complete data were included in the meta-analysis. Our primary outcome was the standardized mean difference, which was equal to the treatment effect in the PEMF group minus the treatment effect in the placebo group divided by the pooled standard deviation. For pain, the standardized mean difference was 1.06 (95% CI = 0.61 to 1.51), for stiffness 0.37 (95% CI = 0.07 to 0.67), for function 0.46 (95% CI = 0.14 to 0.78), and for QOL 1.49 (95% CI = −0.06 to 3.04). PEMF parameters did not influence symptoms. Conclusions: Compared with placebo, there was a beneficial effect of PEMF therapy on pain, stiffness, and physical function in patients with OA. Duration of treatment may not be a critical factor in pain management. Further studies are required to confirm the effects of PEMF therapy on QOL. Impact: Our study suggests that PEMF therapy has clinically significant effects on pain in patients with OA. The current evidence was limited to the short-term effects of PEMF therapy.

1 March 2020 in Osteoarthritis and Cartilage
Verified
Journal Article
Open access
TPT.A. Perry
T.A. Perry
MPM.J. Parkes
M.J. Parkes
RHR.J. Hodgson
R.J. Hodgson
DFD.T. Felson
D.T. Felson
NAN.K. Arden
N.K. Arden
TOT.W. O'NEill
T.W. O'NEill
Bone marrow lesions (BMLs) on MRI are typically subchondral in location, however, a proportion occur at knee ligament attachments and also include a cyst-like component. Our aim was to determine whether the volume of BML subtypes and synovial tissue volume (STV) was associated with symptoms in symptomatic knee OA. Images were acquired in a sub-sample who had taken part in a randomised trial of vitamin D therapy in knee OA (UK-VIDEO). Contrast-enhanced (CE) MRI was performed annually. In those who had ≥1 follow-up and a baseline scan (N = 50), STV and BML volume was assessed. BMLs were categorised by location and by the presence/absence of a cyst-like component. WOMAC was assessed annually. We used fixed-effects panel-regression modelling to examine the association between volume and symptoms. There was no association between knee pain and total subchondral BML volume (b = 0.3 WOMAC units, 95% CI -0.3 to 1.0) or total ligament-based BML volume (b = 1.9, 95% CI -1.6 to 5.3). The volume of subchondral BMLs with a cyst-like component was not associated with pain (b = 0.8, 95% CI -0.5 to 2.1) however, the volume of the cyst-like component itself was associated with pain (b = 51.8, 95% CI 14.2 to 89.3). STV was associated with pain (b = 2.2, 95% CI 0.6 to 3.7). The volume of the cyst-like component from subchondral BMLs with a cyst-like component was associated with knee pain. BML location, however, did not influence symptoms. STV was also associated with knee symptoms.

12 August 2025 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
VBVicky Batchelor
Vicky Batchelor
TPThomas A. Perry
Thomas A. Perry
ZCZameel Cader
Zameel Cader
TVTonia Louise Vincent
Tonia Louise Vincent

10 March 2022 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
LGLucy S. Gates
Lucy S. Gates
TPThomas A. Perry
Thomas A. Perry
YGYvonne M. Golightly
Yvonne M. Golightly
ANAmanda E. Nelson
Amanda E. Nelson
LCLeigh F. Callahan
Leigh F. Callahan
NANigel K. Arden
Nigel K. Arden
Objective: The effect of physical activity on the risk of developing knee osteoarthritis (OA) is unclear. We undertook this study to examine the relationship between recreational physical activity and incident knee OA outcomes using comparable physical activity and OA definitions.Methods: Data were acquired from 6 global, community‐based cohorts of participants with and those without knee OA. Eligible participants had no evidence of knee OA or rheumatoid arthritis at baseline. Participants were followed up for 5–12 years for incident outcomes including the following: 1) radiographic knee OA (Kellgren‐Lawrence [K/L] grade ≥2), 2) painful radiographic knee OA (radiographic OA with knee pain), and 3) OA‐related knee pain. Self‐reported recreational physical activity included sports and walking/cycling activities and was quantified at baseline as metabolic equivalents of task (METs) in days per week. Risk ratios (RRs) were calculated and pooled using individual participant data meta‐analysis. Secondary analysis assessed the association between physical activity, defined as time (hours per week) spent in recreational physical activity and incident knee OA outcomes.Results: Based on a total of 5,065 participants, pooled RR estimates for the association of MET days per week with painful radiographic OA (RR 1.02 [95% confidence interval (95% CI) 0.93–1.12]), radiographic OA (RR 1.00 [95% CI 0.94–1.07]), and OA‐related knee pain (RR 1.00 [95% CI 0.96–1.04]) were not significant. Similarly, the analysis of hours per week spent in physical activity also showed no significant associations with all outcomes.Conclusion: Our findings suggest that whole‐body, physiologic energy expenditure during recreational activities and time spent in physical activity were not associated with incident knee OA outcomes.